{{Rsnum
|rsid=1061235
|Gene=HLA-A
|Chromosome=6
|position=29945521
|Orientation=plus
|GMAF=0.07208
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{PMID Auto GWAS
|PMID=21428769
|Trait=None
|Title=HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans
|RiskAllele=
|Pval=1E-7
|OR=9.1200
|ORtxt=[4.03-20.65]
|OA=1
}}

[[rs1061235]](T) serves as a proxy for the HLA-A*3101 allele.{{PMID|16998491|OA=1
}}

The HLA-A*3101 allele, found in about 2 - 5% of Northern Europeans, is significantly associated with [[carbamazepine]] hypersensitivity syndrome, with odds ratios above 10. The presence of this HLA allele increases the risk from 5% to 26%, whereas its absence reduces the risk from 5% to 4%.{{PMID|21428769|OA=1
}}

{{ClinVar
|rsid=1061235
|Reversed=0
|FwdREF=A
|FwdALT=T
|REF=A
|ALT=T
|RSPOS=29913298
|CHROM=6
|GMAF=0.0719
|dbSNPBuildID=86
|SSR=0
|SAO=0
|VP=0x050168000000150016120100
|GENEINFO=HLA-A:3105
|GENE_NAME=HLA-A
|GENE_ID=3105
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000006.11:g.29913298A>T
|CLNSIG=255
|Tags=PM;PMC;SLO;VLD;G5;KGPhase1;KGPROD;OTHERKG;LSD;MTP
|CAF=0.9279; 0.07208
|CLNACC=RCV000022618.1
|CLNDBN=Carbamazepine hypersensitivity
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=142800.0001
|COMMON=1
|Disease=Carbamazepine hypersensitivity
|CLNDSDB=MedGen
|CLNDSDBID=CN077825
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}